Literature DB >> 30947571

Influence of Surgical Procedures on Serum Paraoxonase-1-Related Variables and Markers of Inflammation in Hospitalized Patients.

Simona Iftimie1, Ana Escribano1, Ariadna Díez-Sans1, Isabela Albiciuc1, Anna Hernández-Aguilera, Isabel Fort-Gallifa, Ana Felisa López-Azcona1, Jordi Camps, Jorge Joven, Antoni Castro1.   

Abstract

Purpose: Surgical stress is a phenomenon not completely understood from the biochemical point of view, although it produces alterations in the oxidative balance and inflammatory status. The present study aimed to investigate the alterations of the circulating levels of paraoxonase-1 (PON1)-related variables and markers of inflammation in hospitalized patients who underwent surgery.
Methods: We recruited 285 hospitalized patients. Of those, 115 were hospitalized due to a surgical intervention and 170 for reasons other than surgery. The control group consisted of 128 healthy volunteers. A blood sample was obtained for the measurement of serum PON1-related variables, and C-reactive protein (CRP), chemokine (C-C motif) ligand 2 (CCL2), and procalcitonin concentrations.
Results: Hospitalized patients had lower serum PON1 activities [paraoxonase: 215.6 (168.6 - 277.8) vs. 298.7 (229.7 - 382.6) U/L, p < 0.001; lactonase: 3.0 (2.3 - 3.7) vs. 5.7 (4.6 - 6.5) U/L, p < 0.001], and higher CCL2, CRP and procalcitonin concentrations than the healthy individuals. The days elapsed following surgery and the duration of the procedure itself inversely correlated with PON1-related variables, and directly correlated with CRP concentrations. Patients that were operated on by laparotomy had higher PON1 activity than patients operated on by laparoscopy. Local and regional anesthesia was associated with higher PON1 activities and lower CRP concentrations.
Conclusion: These results show a decrease in PON1 activities and an increase in acute phase response in hospitalized patients undergoing surgery and support the hypothesis that these phenomena are related to post-surgical metabolic alterations.

Entities:  

Keywords:  C-reactive protein; Inflammation; oxidative stress; paraoxonase-1; surgery

Mesh:

Substances:

Year:  2019        PMID: 30947571     DOI: 10.1080/08941939.2019.1597223

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  5 in total

1.  Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.

Authors:  Mircea Vasile Milaciu; Ștefan Cristian Vesa; Ioana Corina Bocșan; Lorena Ciumărnean; Dorel Sâmpelean; Vasile Negrean; Raluca Maria Pop; Daniela Maria Matei; Sergiu Pașca; Andreea Liana Răchișan; Anca Dana Buzoianu; Monica Acalovschi
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

2.  Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.

Authors:  Siyu Zhou; Qian He; Nengquan Sheng; Jianfeng Gong; Jiazi Ren; Zhigang Wang
Journal:  World J Surg Oncol       Date:  2022-01-15       Impact factor: 2.754

3.  Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia.

Authors:  Donatella Scavone; Micaela Sgorbini; Alexandre S Borges; José P Oliveira-Filho; Valentina Vitale; Saverio Paltrinieri
Journal:  BMC Vet Res       Date:  2020-11-04       Impact factor: 2.741

4.  The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer.

Authors:  Zhang-Zan Huang; Xin Hua; Chen-Ge Song; Wen Xia; Xi-Wen Bi; Zhong-Yu Yuan; Zhen-Yu He; Jia-Jia Huang
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

5.  Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study.

Authors:  Christa Meisinger; Dennis Freuer; Achim Bub; Jakob Linseisen
Journal:  Lipids Health Dis       Date:  2021-07-31       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.